公开(公告)号：US20200078385A1

公开(公告)日：2020-03-12

申请号：US16680054

申请日：2019-11-11

Applicant: ABBOTT LABORATORIES

Inventor： JoMay Chow ,  Steven R. Davis ,  Rachael Buck ,  Geralyn O. Duska-McEwen ,  Hawley K. Linke

IPC: A61K31/702 ,  A23L33/00 ,  A61K31/716 ,  A61K45/06 ,  A23L33/10 ,  A23L33/12 ,  A23L33/19 ,  A23L33/135 ,  A61K9/107 ,  A61K31/733 ,  A61K35/20 ,  A61K35/744 ,  A61K35/745 ,  A61K35/747 ,  A61K36/48 ,  A61K38/01

Abstract: Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective in reducing inflammation and the incidence of inflammatory diseases.

公开(公告)号：US11179406B2

公开(公告)日：2021-11-23

申请号：US16680054

申请日：2019-11-11

Applicant: ABBOTT LABORATORIES

Inventor： JoMay Chow ,  Steven R. Davis ,  Rachael Buck ,  Geralyn O. Duska-McEwen ,  Hawley K. Linke

IPC: A01N63/00 ,  A61K31/702 ,  A23L33/00 ,  A61K31/716 ,  A61K45/06 ,  A23L33/10 ,  A23L33/12 ,  A23L33/19 ,  A23L33/135 ,  A61K9/107 ,  A61K31/733 ,  A61K35/20 ,  A61K35/744 ,  A61K35/745 ,  A61K35/747 ,  A61K36/48 ,  A61K38/01 ,  A61K35/00

Abstract: Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective in reducing inflammation and the incidence of inflammatory diseases.

公开(公告)号：US10471081B2

公开(公告)日：2019-11-12

申请号：US15401488

申请日：2017-01-09

Applicant: ABBOTT LABORATORIES

Inventor： JoMay Chow ,  Steven R. Davis ,  Rachael Buck ,  Geralyn O. Duska-McEwen ,  Hawley K. Linke

IPC: A01N43/04 ,  A61K31/715 ,  A61K31/702 ,  A61K31/716 ,  A61K45/06 ,  A23L33/00 ,  A23L33/10 ,  A23L33/12 ,  A23L33/19 ,  A23L33/135 ,  A61K9/107 ,  A61K31/733 ,  A61K35/20 ,  A61K35/744 ,  A61K35/745 ,  A61K35/747 ,  A61K36/48 ,  A61K38/01 ,  A61K35/00

Abstract: Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective in reducing inflammation and the incidence of inflammatory diseases.

公开(公告)号：US20230338404A1

公开(公告)日：2023-10-26

申请号：US18345357

申请日：2023-06-30

Applicant: ABBOTT LABORATORIES

Inventor： JoMay Chow ,  Steven R. Davis ,  Rachael Buck ,  Geralyn O. Duska-McEwen ,  Hawley K. Linke

IPC: A61K31/702 ,  A23L33/00 ,  A61K31/716 ,  A61K45/06 ,  A23L33/10 ,  A23L33/12 ,  A23L33/19 ,  A23L33/135 ,  A61K9/107 ,  A61K31/733 ,  A61K35/20 ,  A61K35/744 ,  A61K35/745 ,  A61K35/747 ,  A61K36/48 ,  A61K38/01

CPC classification number: A61K31/702 ,  A23L33/40 ,  A61K31/716 ,  A61K45/06 ,  A23L33/10 ,  A23L33/12 ,  A23L33/19 ,  A23L33/30 ,  A23L33/135 ,  A61K9/107 ,  A61K31/733 ,  A61K35/20 ,  A61K35/744 ,  A61K35/745 ,  A61K35/747 ,  A61K36/48 ,  A61K38/018 ,  A23V2002/00 ,  A61K2035/115

Abstract: Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective in reducing inflammation and the incidence of inflammatory diseases.

公开(公告)号：US11690859B2

公开(公告)日：2023-07-04

申请号：US16698422

申请日：2019-11-27

Applicant: ABBOTT LABORATORIES

Inventor： JoMay Chow ,  Steven R. Davis ,  Rachael Buck ,  Geralyn O. Duska-McEwen ,  Hawley K. Linke

IPC: A61K31/70 ,  A01N43/04 ,  A61K31/702 ,  A23L33/00 ,  A61K31/716 ,  A61K45/06 ,  A23L33/10 ,  A23L33/12 ,  A23L33/19 ,  A23L33/135 ,  A61K9/107 ,  A61K31/733 ,  A61K35/20 ,  A61K35/744 ,  A61K35/745 ,  A61K35/747 ,  A61K36/48 ,  A61K38/01 ,  A61K35/00

CPC classification number: A61K31/702 ,  A23L33/10 ,  A23L33/12 ,  A23L33/135 ,  A23L33/19 ,  A23L33/30 ,  A23L33/40 ,  A61K9/107 ,  A61K31/716 ,  A61K31/733 ,  A61K35/20 ,  A61K35/744 ,  A61K35/745 ,  A61K35/747 ,  A61K36/48 ,  A61K38/018 ,  A61K45/06 ,  A23V2002/00 ,  A61K2035/11 ,  A61K2035/115 ,  A61K31/702 ,  A61K2300/00 ,  A61K31/716 ,  A61K2300/00 ,  A23V2002/00 ,  A23V2200/32 ,  A23V2250/282

Abstract: Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective in reducing inflammation and the incidence of inflammatory diseases.

公开(公告)号：US20200093846A1

公开(公告)日：2020-03-26

申请号：US16698422

申请日：2019-11-27

Applicant: ABBOTT LABORATORIES

Inventor： JoMay Chow ,  Steven R. Davis ,  Rachael Buck ,  Geralyn O. Duska-McEwen ,  Hawley K. Linke

IPC: A61K31/702 ,  A61K45/06 ,  A61K38/01 ,  A61K35/744 ,  A23L33/00 ,  A61K31/733 ,  A61K35/20 ,  A23L33/10 ,  A23L33/12 ,  A61K31/716 ,  A23L33/19 ,  A61K36/48 ,  A61K35/747 ,  A61K9/107 ,  A61K35/745 ,  A23L33/135

Abstract: Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective in reducing inflammation and the incidence of inflammatory diseases.

公开(公告)号：US20170224714A1

公开(公告)日：2017-08-10

申请号：US15401488

申请日：2017-01-09

Applicant: ABBOTT LABORATORIES

Inventor： JoMay Chow ,  Steven R. Davis ,  Rachael Buck ,  Geralyn O. Duska-McEwen ,  Hawley K. Linke

IPC: A61K31/702 ,  A61K38/01 ,  A61K35/747 ,  A61K35/745 ,  A61K31/733 ,  A61K35/744 ,  A61K36/48 ,  A61K31/716 ,  A61K35/20 ,  A23L33/00 ,  A23L33/19 ,  A23L33/12 ,  A23L33/135 ,  A23L33/10 ,  A61K9/107

Abstract: Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective in reducing inflammation and the incidence of inflammatory diseases.